Kirby Institute
Clinical trials sponsored by Kirby Institute, explained in plain language.
-
Mass drug showdown: which treatment better fights river blindness?
Disease control Recruiting nowThis large study in Angola compares two approved drugs—moxidectin and ivermectin—to see which works better when given annually to entire communities to control river blindness. Researchers will treat 52,000 people across 20 village groups for four years to measure how well each d…
Phase: PHASE4 • Sponsor: Kirby Institute • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Race against the clock: when should vulnerable patients get their COVID booster?
Disease control Recruiting nowThis study aims to find the best timing for a COVID-19 booster shot for people who need to start treatments that weaken their immune system, such as for cancer or autoimmune diseases. Researchers will compare giving the booster right before treatment starts versus waiting six mon…
Phase: PHASE3 • Sponsor: Kirby Institute • Aim: Disease control
Last updated Mar 03, 2026 14:07 UTC